Insider Transactions in Q1 2024 at Medpace Holdings, Inc. (MEDP)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72
+13.85%
|
-
|
|
Mar 31
2024
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
63
+1.22%
|
-
|
|
Mar 31
2024
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
79
+0.36%
|
-
|
|
Mar 15
2024
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
102
-0.67%
|
$41,106
$403.0 P/Share
|
|
Mar 14
2024
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
250
-50.0%
|
$102,250
$409.87 P/Share
|
|
Mar 14
2024
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$42,000
$84.36 P/Share
|
|
Mar 08
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.53%
|
$10,200,000
$408.71 P/Share
|
|
Mar 08
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.53%
|
$10,200,000
$408.71 P/Share
|
|
Mar 07
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
75,000
-1.55%
|
$30,750,000
$410.74 P/Share
|
|
Mar 07
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
75,000
-1.55%
|
$30,750,000
$410.74 P/Share
|
|
Mar 07
2024
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
472
-100.0%
|
$195,880
$415.0 P/Share
|
|
Mar 07
2024
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
472
+50.0%
|
$25,488
$54.99 P/Share
|
|
Mar 06
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.03%
|
$41,200,000
$412.98 P/Share
|
|
Mar 06
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-2.03%
|
$41,200,000
$412.98 P/Share
|
|
Mar 05
2024
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
17,679
+45.12%
|
$1,591,110
$90.65 P/Share
|
|
Mar 05
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-1.0%
|
$20,100,000
$402.7 P/Share
|
|
Mar 05
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-1.0%
|
$20,100,000
$402.7 P/Share
|
|
Mar 04
2024
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
22,321
-85.37%
|
$8,995,363
$403.03 P/Share
|
|
Mar 04
2024
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
22,321
+46.06%
|
$2,008,890
$90.65 P/Share
|
|
Mar 04
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.99%
|
$20,150,000
$403.12 P/Share
|
|
Mar 04
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.99%
|
$20,150,000
$403.12 P/Share
|
|
Mar 01
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
80,000
-1.56%
|
$32,080,000
$401.88 P/Share
|
|
Mar 01
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
80,000
-1.56%
|
$32,080,000
$401.88 P/Share
|
|
Mar 01
2024
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
350
-2.56%
|
$140,000
$400.79 P/Share
|
|
Feb 29
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.39%
|
$7,860,000
$393.71 P/Share
|
|
Feb 29
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
20,000
-0.39%
|
$7,860,000
$393.71 P/Share
|
|
Feb 29
2024
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
1,163
-7.83%
|
$457,059
$393.5 P/Share
|
|
Feb 29
2024
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
2,558
-40.08%
|
$1,005,294
$393.5 P/Share
|
|
Feb 28
2024
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$202,500
$405.0 P/Share
|
|
Feb 28
2024
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$27,000
$54.99 P/Share
|
|
Feb 28
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.96%
|
$20,200,000
$404.13 P/Share
|
|
Feb 28
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.96%
|
$20,200,000
$404.13 P/Share
|
|
Feb 27
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.96%
|
$20,050,000
$401.88 P/Share
|
|
Feb 27
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.96%
|
$20,050,000
$401.88 P/Share
|
|
Feb 26
2024
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
500
-74.6%
|
$202,000
$404.29 P/Share
|
|
Feb 26
2024
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$27,000
$54.99 P/Share
|
|
Feb 26
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
56,928
-1.08%
|
$22,885,056
$402.38 P/Share
|
|
Feb 26
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
56,928
-1.08%
|
$22,885,056
$402.38 P/Share
|
|
Feb 23
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-1.86%
|
$40,000,000
$400.32 P/Share
|
|
Feb 23
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-1.86%
|
$40,000,000
$400.32 P/Share
|
|
Feb 22
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-1.82%
|
$39,500,000
$395.98 P/Share
|
|
Feb 22
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-1.82%
|
$39,500,000
$395.98 P/Share
|
|
Feb 21
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
36,012
-0.65%
|
$13,792,596
$383.44 P/Share
|
|
Feb 21
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
36,012
-0.65%
|
$13,792,596
$383.44 P/Share
|
|
Feb 20
2024
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,782
+38.96%
|
$358,332
$26.44 P/Share
|
|
Feb 20
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,988
-0.25%
|
$5,399,368
$386.39 P/Share
|
|
Feb 20
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
13,988
-0.25%
|
$5,399,368
$386.39 P/Share
|
|
Feb 16
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.89%
|
$19,550,000
$391.75 P/Share
|
|
Feb 16
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.89%
|
$19,550,000
$391.75 P/Share
|
|
Feb 08
2024
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,710
+48.32%
|
$268,470
$57.17 P/Share
|